•
Aug 31, 2020

Neogen Q1 2021 Earnings Report

Neogen's revenue and net income increased due to the diversity of its portfolio of products and services.

Key Takeaways

Neogen Corporation reported an 8% increase in revenues and an increase in net income for the first quarter of fiscal year 2021. The company's food safety segment faced disruption, but strong growth in genomics and biosecurity products helped offset the impact.

Revenues for the first quarter of fiscal year 2021 were $109,325,000, an 8% increase compared to the previous year's first quarter revenues of $101,424,000.

Net income for the first quarter was $15,860,000, or $0.30 per share, compared to $14,652,000, or $0.28 per share, in the previous year's first quarter.

The Food Safety segment's revenues were $54,185,000, compared to $51,021,000 in the prior year's first quarter, driven by higher sales of disinfectants, hand sanitizers, and insecticides.

The Animal Safety segment reported revenues of $55,140,000, compared to $50,403,000 in the prior year first quarter, driven by rodenticides and genomics services.

Total Revenue
$109M
Previous year: $101M
+7.8%
EPS
$0.15
Previous year: $0.14
+7.1%
Gross Profit
$50.3M
Previous year: $48.2M
+4.4%
Cash and Equivalents
$60.9M
Previous year: $56.3M
+8.3%
Total Assets
$822M
Previous year: $721M
+13.9%

Neogen

Neogen

Neogen Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income